Ventana Seeks To Automate Inform HER-2/neu After $5.5 Mil. Oncor Purchase
This article was originally published in The Gray Sheet
Executive Summary
Ventana Medical Systems says it plans to launch by the third quarter of 1999 an automated version of Oncor's Inform HER-2/neu test for predicting recurrence of breast cancer.